StockMacro
Menu

Invivyd

$0.41 -62% in 6 monthsMarket cap $122.0M

IVVD on XNAS, Health Care, Invivyd, Inc., job postings

Measures activity, not value. Not investment advice.

Revenue up 21% to $60.7M but shares fell 83% in 12 months with a $130.3M loss.

  • BadShort interest at 12% of shares, with 9.7 days to cover
  • GoodInstitutional holders rose from 124 to 134 in the quarter

Written by AI from the data on this page, 22 Nov 2026. Not investment advice.

Profile and fundamentals

From its SEC filings, 12 months to 30 Sep 2026

Invivyd Inc is a biopharmaceutical company focused on the discovery, development, and commercialization of monoclonal antibody (mAb) therapies for the prevention and treatment of serious viral infectious diseases. Its lead product, PEMGARDA (pemivibart), received emergency use authorization from the U.S. FDA for the pre-exposure prevention of COVID-19 in certain immunocompromised individuals. The company is also developing next-generation antibody candidates, including VYD2311 for COVID-19 and VBY329 for RSV infections, while continuing research on additional antibodies targeting other viral diseases such as measles.

Industry
Biological products, (no diagnostic substances) (Health Care)
Employees
122
Website
invivyd.com
Listed
Nasdaq, US
Last results
16 Nov 2026
Next results
expected around 7 Jan 2027 (an estimate: a year ago it reported on 8 Jan 2026)
Revenue and net income per quarter. Quarter to 30 Sep 2026: revenue $15.4M, net loss $33.5M.
Quarter to 31 Dec 2021: revenue –, net income -$83.0MQuarter to 31 Mar 2022: revenue –, net income -$100.7MQuarter to 30 Jun 2022: revenue –, net income -$51.0MQuarter to 30 Sep 2022: revenue –, net income -$45.1MQuarter to 31 Dec 2022: revenue –, net income -$44.6MQuarter to 31 Mar 2023: revenue –, net income -$35.3MQuarter to 30 Jun 2023: revenue $0, net income -$50.2MQuarter to 30 Jun 2023: revenue $0, net income -$50.2MQuarter to 30 Sep 2023: revenue $0, net income -$39.4MQuarter to 30 Sep 2023: revenue $0, net income -$39.4MQuarter to 31 Dec 2023: revenue $0, net income -$73.7MQuarter to 31 Dec 2023: revenue $0, net income -$73.7MQuarter to 31 Mar 2024: revenue $0, net income -$43.5MQuarter to 31 Mar 2024: revenue $0, net income -$43.5MQuarter to 30 Jun 2024: revenue $2.3M, net income -$47.2MQuarter to 30 Jun 2024: revenue $2.3M, net income -$47.2MQuarter to 30 Sep 2024: revenue $9.3M, net income -$60.7MQuarter to 30 Sep 2024: revenue $9.3M, net income -$60.7MQuarter to 31 Dec 2024: revenue $13.8M, net income -$18.4MQuarter to 31 Dec 2024: revenue $13.8M, net income -$18.4MQuarter to 31 Mar 2025: revenue $11.3M, net income -$16.3MQuarter to 31 Mar 2025: revenue $11.3M, net income -$16.3MQuarter to 30 Jun 2025: revenue $11.8M, net income -$14.7MQuarter to 30 Jun 2025: revenue $11.8M, net income -$14.7MQuarter to 30 Sep 2025: revenue $13.1M, net income -$10.5MQuarter to 30 Sep 2025: revenue $13.1M, net income -$10.5MQuarter to 31 Dec 2025: revenue $17.2M, net income -$11.1MQuarter to 31 Dec 2025: revenue $17.2M, net income -$11.1MQuarter to 31 Mar 2026: revenue $13.7M, net income -$41.4MQuarter to 31 Mar 2026: revenue $13.7M, net income -$41.4MQuarter to 30 Jun 2026: revenue $14.3M, net income -$44.4MQuarter to 30 Jun 2026: revenue $14.3M, net income -$44.4MQuarter to 30 Sep 2026: revenue $15.4M, net income -$33.5MQuarter to 30 Sep 2026: revenue $15.4M, net income -$33.5M
31 Dec 2021RevenueNet incomeNet losstallest bar $100.7M30 Sep 2026
See the numbers
Quarter toRevenueNet income
30 Sep 2026$15.4M-$33.5M
30 Jun 2026$14.3M-$44.4M
31 Mar 2026$13.7M-$41.4M
31 Dec 2025$17.2M-$11.1M
30 Sep 2025$13.1M-$10.5M
30 Jun 2025$11.8M-$14.7M
31 Mar 2025$11.3M-$16.3M
31 Dec 2024$13.8M-$18.4M
30 Sep 2024$9.3M-$60.7M
30 Jun 2024$2.3M-$47.2M
31 Mar 2024$0-$43.5M
31 Dec 2023$0-$73.7M
30 Sep 2023$0-$39.4M
30 Jun 2023$0-$50.2M
31 Mar 2023–-$35.3M
31 Dec 2022–-$44.6M
30 Sep 2022–-$45.1M
30 Jun 2022–-$51.0M
31 Mar 2022–-$100.7M
31 Dec 2021–-$83.0M
Fundamentals, 12 months to 30 Sep 2026
MeasureLatestYear beforePeer median
RevenueSales over the last 12 months reported. $60.7M $50.0M
Revenue growthRevenue of the last 12 months compared with the 12 months before. +21% +8.2%
Net incomeProfit after all costs and taxes over the last 12 months reported. Negative is a loss. -$130.3M -$59.9M
EPS (diluted)Earnings per share: net income divided by the shares, counting options and convertibles. Left blank when the figures as filed do not fit today's share count (after a split). -$0.37 -$0.47
Gross marginWhat is left of each dollar of sales after the direct cost of making the product or service. – – 70.4%
Operating marginOperating income as a share of sales: profit from the business before interest and taxes. -224% -124% -98.6%
Net marginNet income as a share of sales: what the owners keep of each dollar sold. -215% -120% -47.8%
Return on equityNet income of the last 12 months divided by shareholders' equity (the average of the latest balance sheet and the one a year earlier): the profit made on the owners' money. -107% -58.2%
Free cash flowCash from operations minus capital spending over the last 12 months: cash the business produced. – –
CashCash, cash equivalents and short-term investments on the latest balance sheet. $126.4M $85.0M
DebtShort- and long-term borrowings on the latest balance sheet. Operating leases are not counted. – $1.0B
Net debtDebt minus cash. Negative means the company holds more cash than it owes (net cash). – $915.0M
Debt to equityDebt divided by shareholders' equity on the latest balance sheet: how much is borrowed for each dollar the owners have in the company. Blank when equity is negative. – 0.0
Book value per shareShareholders' equity (assets minus liabilities) on the latest balance sheet divided by the shares outstanding. $0.51
P/EPrice to earnings: market cap divided by net income of the last 12 months. What investors pay for one dollar of yearly profit. Blank when the company made a loss. loss 21.6
P/SPrice to sales: market cap divided by revenue of the last 12 months. 2.0 8.0
EV/SalesEnterprise value (market cap plus debt minus cash) divided by revenue of the last 12 months. – 6.0
P/BPrice to book: market cap divided by shareholders' equity on the latest balance sheet. Blank when equity is negative. 0.81 2.0

Latest = 12 months to 30 Sep 2026; balance-sheet lines at its end. Peer median: companies in the same industry (SIC code), or the sector when the industry is small.

Peers nearest by market cap, its own industry first

CompanyMarket capP/EP/SRevenue growthNet margin
InvivydIVVD (this company) $122.0Mloss2.0+21%-215%
HumacyteHUMA $123.7Mloss51.6+53%–
Compass TherapeuticsCMPX $123.9Mloss–––
enGene TherapeuticsENGN $116.6Mloss–––
Armata PharmaceuticalsARMP $112.7Mloss–––
Fate TherapeuticsFATE $111.8Mloss23.5-33%–

Insider Buy/Sell Shares the company's insiders (directors, officers and owners of 10% or more) bought minus what they sold on the open market in the last 90 days, from their Form 4 filings.

–

No data for this company

Institutional holders The number of institutional investment managers (13F filers: funds, pensions, asset managers) reporting the stock, compared with the quarter before. 13F reports are public 45 days after quarter end and show long positions only.

+8.1%

134 13F filers vs 124

Institutional ownership Shares held by 13F filers at the latest quarter end, divided by the shares outstanding in the company's latest filing. Above 100% usually means a stale share count or double counting, and is marked.

74%

218.5M shares held by 13F filers (30 Sep 2026) of 295.6M outstanding (29 Oct 2026)

Short interest Shares sold short and not yet bought back, divided by the shares outstanding in the company's latest filing. From FINRA's latest short interest report: FINRA reports twice a month and publishes 7 business days after the settlement date. Above 100% means a stale share count, and is marked.

12%

36.2M shares sold short (30 Oct 2026) of 295.6M outstanding (29 Oct 2026)

Days to cover Short interest divided by the stock's average daily trading volume, as FINRA publishes it: how many days of normal trading it would take short sellers to buy back every share. Latest report.

9.7

36.2M shares sold short (30 Oct 2026) divided by the stock's average daily volume, as FINRA publishes it

Short interest change How the number of shares sold short changed between FINRA's two latest reports, about two weeks apart.

-2.3%

37.0M shares sold short in the report before, 36.2M on 30 Oct 2026

Short sale volume Share of the stock's latest daily volume on FINRA-reported off-exchange venues that was sold short. Market makers sell short routinely, so 40% to 50% is normal; compare it with the company's own 1-year average in the cell's details. A daily flow, not short interest.

44%

44% of off-exchange volume on 20 Nov 2026 was short sales; 1-year average 49%

Open jobs Job postings open on the company's own careers site today, where we track it. Blank when we do not track this company's careers site yet.

12

Tracked since 20 Nov 2026

Open jobs change How the number of open job postings changed over the last 30 days: total hiring demand, any job, any country. Shown only once we have tracked the company for 30 days.

–

Tracking started 20 Nov 2026; the change shows after 30 days.

Employees Total staff the company reported in its latest annual report (10-K), with the change from the year before when both years are reported.

–

No headcount in its annual reports in our data.

Visa hiring (foreign workers) Applications to hire foreign specialists on H-1B and E-3 visas certified by the Labor Department in the last 12 months, compared with the 12 months before. This is NOT total hiring: most hires need no visa. Open jobs shows total hiring where we track it.

–

No data for this company

Revenue growth Sales in the latest reported quarter compared with the same quarter a year earlier.

+18%

$15.4M vs $13.1M (quarter ended 30 Sep 2026)

Capital spending Money spent on buildings, machines and equipment in the latest quarter, compared with the same quarter a year earlier.

–

No data for this company

Federal contracts Money the US government committed to the company in contracts and grants over the last 12 months.

–

No data for this company

Lobbying What the company reported spending on federal lobbying over the last four quarters.

$460K

4 quarters, $

Layoff notices Workers named in state WARN layoff notices over the last 12 months (employers must file them 60 days before a large layoff).

–

No data for this company

News (7d) Articles about the company published in the last 7 days, from our Google News collection (one search per company, every half hour). Blank when we do not collect news for this company.

13

13 articles in the last 7 days; its usual week has 1 (the median of the 26 weeks before).

News vs usual Articles in the last 7 days divided by the company's usual week: the median week of the 26 weeks before. Blank when the usual week has fewer than one article.

13×

13 articles in the last 7 days; its usual week has 1.

Price $0.41 on 20 Nov 2026, -83% over 12 months (12-month range $0.41 to $2.88)

  • Sharp change
  • 8-K and other filings
  • Lobbying filing
Insider net buying (open market). Insiders sold a net $436K in the last 12 months (the 12 months before: -$848K).
Revenue per quarter. Revenue $15.4M in the latest quarter, +18% on a year earlier.
Capital spending per quarter. Capital spending $585K in the latest quarter.
Institutional holders (13F filers). 134 13F filers reported holding it in the latest 13F quarter, +79% on a year earlier.
Lobbying spend. Lobbying spend: $460K published in the last 12 months (none in the 12 months before).

Every point sits on the day the fact became public (filing acceptance or publication), not the day it happened; prices through 20 Nov 2026. Hover or tap a marker for the fact; click it for the evidence or the source. No data here for: h-1b/e-3 applications certified, federal obligations, workers in warn layoff notices.

See the numbers
Dated facts on the price chart (newest 100)
Became publicKindFact
1 Sep 20268-K and other filingsDirector or officer change
1 Sep 2026Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
24 Jul 20268-K and other filingsDelisting notice or listing transfer
20 Jul 2026Sharp changeLobbying on a new issue: lobbying on a new issue: MAN (2026-06-30)
28 Apr 2026Lobbying filinglobbying engagement terminated (KING & SPALDING LLP)
3 Mar 2026Sharp changeShort interest spike: short interest spike, 22.7M vs usual 7.7M (2026-02-13); 2.7x the same period a year earlier
17 Feb 2026Sharp changeMany funds opening a new position: many funds opening a new position, 46 vs usual 15.50 (2025-12-31); 5.1x the same period a year earlier
17 Feb 2026Sharp changeShort interest spike: short interest spike, 22.3M vs usual 7.4M (2026-01-30); 3.4x the same period a year earlier
3 Feb 2026Sharp changeShort interest spike: short interest spike, 21.4M vs usual 7.1M (2026-01-15); 3.4x the same period a year earlier
23 Jan 2026Lobbying filingnew lobbying registration (KING & SPALDING LLP)
13 Jan 2026Sharp changeShort interest spike: short interest spike, 35.6M vs usual 6.8M (2025-12-31); 8.9x the same period a year earlier
30 Dec 2025Sharp changeShort interest spike: short interest spike, 28.6M vs usual 6.6M (2025-12-15); 7.8x the same period a year earlier
19 Dec 2025Lobbying filingnew lobbying registration (FORBES-TATE)
16 Dec 2025Sharp changeShort interest spike: short interest spike, 28.2M vs usual 6.6M (2025-11-28); 5.8x the same period a year earlier
2 Dec 2025Sharp changeShort interest spike: short interest spike, 27.5M vs usual 6.6M (2025-11-14); 4.1x the same period a year earlier
18 Nov 2025Sharp changeShort interest spike: short interest spike, 24.1M vs usual 6.6M (2025-10-31); 2.9x the same period a year earlier
28 Oct 2025Sharp changeShort interest spike: short interest spike, 16.7M vs usual 6.6M (2025-10-15); 2.3x the same period a year earlier
24 Sep 20258-K and other filingsDirector or officer change
24 Sep 2025Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
19 Aug 2025Sharp changeQuarterly revenue change: quarterly revenue change, 11.8M vs usual 1.1M (2025-06-30); 5.2x the same period a year earlier
20 May 2025Sharp changeQuarterly revenue change: quarterly revenue change, 11.3M vs usual 0 (2025-03-31)
25 Apr 20258-K and other filingsDelisting notice or listing transfer
26 Mar 20258-K and other filingsDirector or officer change
26 Mar 2025Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
27 Dec 20248-K and other filingsDelisting notice or listing transfer
2 Dec 20248-K and other filingsDirector or officer change
2 Dec 2024Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
7 Nov 2024Lobbying filinglobbying engagement terminated (EAST END GROUP, LLC)
1 Oct 2024Sharp changeShort interest spike: short interest spike, 7.4M vs usual 2.6M (2024-09-13); 3.5x the same period a year earlier
17 Sep 2024Sharp changeShort interest spike: short interest spike, 7.6M vs usual 2.4M (2024-08-30); 3.9x the same period a year earlier
27 Aug 2024Sharp changeShort interest spike: short interest spike, 7.9M vs usual 2.4M (2024-08-15); 3.3x the same period a year earlier
13 Aug 2024Sharp changeShort interest spike: short interest spike, 7.8M vs usual 2.4M (2024-07-31); 3.4x the same period a year earlier
30 Jul 2024Sharp changeShort interest spike: short interest spike, 7.6M vs usual 2.3M (2024-07-15); 3.6x the same period a year earlier
18 Jul 2024Sharp changeLobbying on a new issue: lobbying on a new issue: BUD, DIS (2024-06-30)
16 Jul 2024Sharp changeShort interest spike: short interest spike, 7.1M vs usual 2.3M (2024-06-28); 3.2x the same period a year earlier
3 Jul 2024Lobbying filinglobbying engagement terminated (CGCN GROUP, LLC)
2 Jul 2024Sharp changeShort interest spike: short interest spike, 6.8M vs usual 2.3M (2024-06-14); 2.3x the same period a year earlier
18 Jun 2024Sharp changeShort interest spike: short interest spike, 6.9M vs usual 2.3M (2024-05-31); 2.8x the same period a year earlier
31 May 2024Lobbying filinglobbying engagement terminated (INVIVYD, INC.)
31 May 20248-K and other filingsDirector or officer change
28 May 2024Sharp changeShort interest spike: short interest spike, 6.2M vs usual 2.3M (2024-05-15); 2.0x the same period a year earlier
21 May 2024Sharp changeMany funds opening a new position: many funds opening a new position, 29 vs usual 10.50 (2024-03-31); 4.8x the same period a year earlier
14 May 2024Sharp changeShort interest spike: short interest spike, 5.9M vs usual 2.3M (2024-04-30); 1.9x the same period a year earlier
6 May 2024Lobbying filingnew lobbying registration (EAST END GROUP, LLC)
30 Apr 2024Sharp changeShort interest spike: short interest spike, 4.2M vs usual 2.3M (2024-04-15); 1.4x the same period a year earlier
23 Apr 2024Lobbying filinglobbying engagement terminated (THE MCMANUS GROUP)
12 Apr 20248-K and other filingsDirector or officer change
2 Apr 2024Lobbying filingnew lobbying registration (CGCN GROUP, LLC)
9 Feb 20248-K and other filingsDirector or officer change
9 Feb 2024Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
5 Sep 20238-K and other filingsDirector or officer change
27 Jul 20238-K and other filingsDirector or officer change
2 May 20238-K and other filingsDirector or officer change
2 May 2023Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
6 Dec 20228-K and other filingsDirector or officer change
29 Nov 20228-K and other filingsPrivate placement of securities (Form D)
24 Oct 20228-K and other filingsDirector or officer change
13 Oct 20228-K and other filingsDirector or officer change
13 Oct 2022Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
17 Jul 2022Lobbying filingnew lobbying registration (INVIVYD, INC.)
5 Jul 20228-K and other filingsDirector or officer change
30 Jun 20228-K and other filingsDirector or officer change
21 Jun 20228-K and other filingsDirector or officer change
21 Jun 2022Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
22 Mar 2022Lobbying filingnew lobbying registration (THE MCMANUS GROUP)
21 Mar 20228-K and other filingsDirector or officer change
1 Mar 20228-K and other filingsDirector or officer change
23 Feb 20228-K and other filingsDirector or officer change
18 Feb 20228-K and other filingsDirector or officer change
20 Jan 2022Lobbying filinglobbying engagement terminated (BELL & LINDSAY, INC.)
Insider net buying (open market)
Month from 1 Aug 2022: $12.2M published
Month from 1 Sep 2022: $36K published
Month from 1 Jan 2024: -$19.8M published
Month from 1 Jun 2024: -$187K published
Month from 1 Dec 2024: -$704K published
Month from 1 Jan 2025: -$132K published
Month from 1 Aug 2025: -$137K published
Month from 1 Nov 2025: $125K published
Month from 1 Feb 2026: -$291K published
Month from 1 Aug 2026: -$145K published
Revenue per quarter
Quarter ended 30 Jun 2023: $0; public on 15 Aug 2024
Quarter ended 30 Sep 2023: $0; public on 15 Nov 2024
Quarter ended 31 Dec 2023: $0; public on 21 Mar 2025
Quarter ended 31 Mar 2024: $0; public on 16 May 2025
Quarter ended 30 Jun 2024: $2.3M; public on 15 Aug 2024
Quarter ended 30 Sep 2024: $9.3M; public on 15 Nov 2024
Quarter ended 31 Dec 2024: $13.8M; public on 21 Mar 2025
Quarter ended 31 Mar 2025: $11.3M; public on 16 May 2025
Quarter ended 30 Jun 2025: $11.8M, +421% on a year earlier; public on 15 Aug 2025
Quarter ended 30 Sep 2025: $13.1M, +41% on a year earlier; public on 7 Nov 2025
Quarter ended 31 Dec 2025: $17.2M, +25% on a year earlier; public on 6 Mar 2026
Quarter ended 31 Mar 2026: $13.7M, +22% on a year earlier; public on 15 May 2026
Quarter ended 30 Jun 2026: $14.3M, +21% on a year earlier; public on 14 Aug 2026
Quarter ended 30 Sep 2026: $15.4M, +18% on a year earlier; public on 17 Nov 2026
Capital spending per quarter
Quarter ended 30 Sep 2021: $0; public on 11 Nov 2022
Quarter ended 31 Dec 2021: $84K; public on 1 Apr 2022
Quarter ended 31 Mar 2022: $0; public on 12 May 2023
Quarter ended 30 Sep 2022: $477K; public on 11 Nov 2022
Quarter ended 31 Dec 2022: $1.2M, +1342% on a year earlier; public on 24 Mar 2023
Quarter ended 30 Sep 2023: $0, -100% on a year earlier; public on 10 Nov 2023
Quarter ended 31 Dec 2023: $0, -100% on a year earlier; public on 29 Mar 2024
Quarter ended 31 Mar 2024: $140K; public on 10 May 2024
Quarter ended 30 Sep 2024: $5K; public on 15 Nov 2024
Quarter ended 31 Mar 2025: $144K, +2.9% on a year earlier; public on 16 May 2025
Quarter ended 30 Jun 2025: $11K; public on 15 Aug 2025
Quarter ended 31 Mar 2026: $726K, +404% on a year earlier; public on 15 May 2026
Quarter ended 30 Jun 2026: $510K, +4536% on a year earlier; public on 14 Aug 2026
Quarter ended 30 Sep 2026: $585K; public on 17 Nov 2026
Institutional holders (13F filers)
31 Dec 2021 report: 69; public on 14 Feb 2022
31 Mar 2022 report: 70; public on 16 May 2022
30 Jun 2022 report: 72; public on 15 Aug 2022
30 Sep 2022 report: 70; public on 14 Nov 2022
31 Dec 2022 report: 74; public on 14 Feb 2023
31 Mar 2023 report: 68; public on 15 May 2023
30 Jun 2023 report: 55; public on 14 Aug 2023
30 Sep 2023 report: 55; public on 14 Nov 2023
31 Dec 2023 report: 56; public on 14 Feb 2024
31 Mar 2024 report: 84; public on 15 May 2024
30 Jun 2024 report: 76; public on 14 Aug 2024
30 Sep 2024 report: 74; public on 14 Nov 2024
31 Dec 2024 report: 77; public on 14 Feb 2025
31 Mar 2025 report: 77; public on 15 May 2025
30 Jun 2025 report: 65; public on 14 Aug 2025
30 Sep 2025 report: 75; public on 14 Nov 2025
31 Dec 2025 report: 110; public on 17 Feb 2026
31 Mar 2026 report: 136; public on 15 May 2026
30 Jun 2026 report: 124; public on 14 Aug 2026
30 Sep 2026 report: 134; public on 16 Nov 2026
Lobbying spend
Quarter from 1 Apr 2022: $10K published
Quarter from 1 Jul 2022: $120K published
Quarter from 1 Oct 2022: $120K published
Quarter from 1 Jan 2023: $120K published
Quarter from 1 Apr 2023: $120K published
Quarter from 1 Jul 2023: $120K published
Quarter from 1 Oct 2023: $120K published
Quarter from 1 Jan 2024: $120K published
Quarter from 1 Apr 2024: $120K published
Quarter from 1 Jul 2024: $87K published
Quarter from 1 Oct 2024: $6K published
Quarter from 1 Jan 2026: $20K published
Quarter from 1 Apr 2026: $80K published
Quarter from 1 Jul 2026: $180K published
Quarter from 1 Oct 2026: $180K published

What is unusual now

  • Nothing unusual in the last 90 days: no change appeared. Its most unusual measure now is 13F holders (funds reporting the stock) at 134 (30 Sep 2026), 1.8× its normal reading; higher than 95% of its own history.
  • Lobbying on a new issue: lobbying on a new issue Public on 20 Jul 2026.
  • Insider net buying (open market): Insiders sold a net $436K in the last 12 months (the 12 months before: -$848K).
  • Revenue per quarter: Revenue $15.4M in the latest quarter, +18% on a year earlier.

Latest records

The names and amounts behind the totals, newest first

Insider trades

All 29 insider trades

No trades in the last 90 days; the latest was filed 18 Aug 2026. Open-market trades by officers, directors and 10% owners.

FiledInsiderTradeSharesPriceValueSource
18 Aug 2026William E. DukeChief Financial OfficerSellplanned in advance (10b5-1); after exercising options40,780$0.77$32KForm 4
18 Aug 2026Robert D. Allen IIIChief Scientific OfficerSellplanned in advance (10b5-1); after exercising options37,722$0.77$29KForm 4
18 Aug 2026Jill AndersenChief Legal Officer, SecretarySellplanned in advance (10b5-1); after exercising options67,962$0.77$53KForm 4
18 Aug 2026Timothy Edward LeeChief Commercial OfficerSellplanned in advance (10b5-1); after exercising options40,780$0.77$32KForm 4
18 Feb 2026Timothy Edward LeeChief Commercial OfficerSellplanned in advance (10b5-1); after exercising options40,627$1.56$63KForm 4
18 Feb 2026Jill AndersenChief Legal Officer, SecretarySellplanned in advance (10b5-1); after exercising options67,710$1.56$106KForm 4
18 Feb 2026William E. DukeChief Financial OfficerSellplanned in advance (10b5-1); after exercising options40,627$1.56$63KForm 4
18 Feb 2026Robert D. Allen IIIChief Scientific OfficerSellplanned in advance (10b5-1); after exercising options37,581$1.56$59KForm 4

134 institutions reported shares at the end of Q3 2026, 74% of the shares outstanding; 26 opened a position, 17 sold out. From 13F reports.

InstitutionShares% of companyValueChange vs Q2 2026
Janus Henderson Group Ltd.36.0M12.2%$31.4M
BVF Inc28.2M9.53%$24.5MNo change
Maverick Capital Ltd24.4M8.27%$21.3M+5.5M+29%
BlackRock, Inc.16.6M5.61%$14.4M+442K+2.7%
Perceptive Advisors LLC13.8M4.66%$12.0M-4.7M-26%
Vanguard Capital Management LLC11.0M3.71%$9.6M+483K+4.6%
M28 Capital Management LP9.2M3.13%$8.0MNo change
Soleus Capital Management, L.P.7.5M2.55%$6.5M-184K-2.4%
Point72 Asset Management, L.P.6.9M2.33%$6.0M-661K-8.8%
Morgan Stanley5.9M2.01%$5.2M+206K+3.6%

Company events

All 36 company events

In 12 months: 1 delisting notice, 1 director or officer change. Results releases and routine reports are left out.

FiledWhat happenedSource
1 Sep 2026Director or officer change8-K
24 Jul 2026Delisting notice or listing transfer8-K
19 Nov 2025Signed a major agreement8-K
24 Sep 2025Director or officer change8-K
22 Aug 2025Signed a major agreement8-K
25 Apr 2025Delisting notice or listing transfer8-K
21 Apr 2025Signed a major agreementSame filing: took on new debt8-K
26 Mar 2025Director or officer change8-K

12 open postings; careers site tracked since 20 Nov 2026. Most in Sales & business development 58%, Marketing & communications 17%, Program & project management 17%, Legal, policy & compliance 8%.

PostedJobLocation
13 Oct 2026Strategic Account Manager, BostonSales & business developmentRemote (Boston)
6 Oct 2026Field Reimbursement ManagerProgram & project managementRemote (DC, NJ, Maryland)
30 Sep 2026Senior Director, Strategic IDNs and Health System AccessProgram & project managementRemote
24 Sep 2026Senior Virology Care Specialist/Strategic Account Manager, North FloridaSales & business developmentRemote (North Florida)
14 Sep 2026Regional Sales Director, MidwestSales & business developmentRemote (Chicago, Minneapolis, St. Louis, Kansas City)
14 Aug 2026Regional Sales DirectorSales & business developmentRemote (Philadelphia or Washington D.C.)
1 Jul 2026Senior Virology Care Specialist/Strategic Account Manager, ConnecticutSales & business developmentRemote (Connecticut)
3 Jun 2026Strategic Account Manager, Los AngelesSales & business developmentRemote (Los Angeles)

Reported lobbying spend: $180K in Q3 2026, $180K in Q2 2026. Rows are lobbying firms hired or let go; amounts are reported per quarter, not per firm here.

DateChangeLobbying firmIssueSource
28 Apr 2026EndedKing & Spalding LLPfor Invivyd, Inc.Not statedFiling
5 Jan 2026NewKing & Spalding LLPfor Invivyd, Inc.Biopharmaceuticals, Monoclonal Antibodies, Infectious diseases, Onshoring.Health issues, ManufacturingFiling
10 Dec 2025NewForbes-Tatefor InvivydIssues related to infectious diseases.Health issuesFiling
1 Aug 2024EndedEast End Group, LLCfor Invivyd, Inc.Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act; Funding for the Public Health Social Services Emergency Fund (PHSSEF)- Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield; Education and awareHealth issuesFiling
30 Jun 2024EndedCGCN Group, LLCfor Invivyd, Inc.Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act; Funding for the Public Health Social Services Emergency Fund (PHSSEF) - Strategic National Stockpile (SNS); Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield; Education and awarDIS, Budget, Health issuesFiling
26 Feb 2024NewCGCN Group, LLCfor Invivyd, Inc.Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act; Funding for the Public Health Social Services Emergency Fund (PHSSEF)- Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield; Education and awareDIS, Budget, Health issuesFiling
11 Feb 2024EndedThe Mcmanus Groupfor Invivyd (Formerly Known As Adagio Therapeutics))Education and awareness related to COVID-19 therapeutics. Issues related to H.R.4421 Preparing for All Hazards and Pathogens Reauthorization Act and S.2333 - Pandemic and All-Hazards Preparedness and Response ActHealth issuesFiling
1 Feb 2024EndedInvivyd, Inc.its own lobbyistsNot statedFiling

The 5 newest of 91 articles that name the company.

Timeline

Several things at once

Two or more unrelated kinds of records unusual within 30 days

17 Feb 2026confirmed

Confirmed across sources Institutional holdings and Short interest and volume

Invivyd (IVVD): had 21.4M shares sold short in the 15 Jan 2026 report, 3.4× the same report last year, while it saw 46 13F filers open a new position in the quarter ended 31 Dec 2025, 5.1× the same quarter last year. Two unrelated kinds of activity within 28 days.

  • Short interest and volume: Short interest spike, became public on 28 Jan 2026
  • Institutional holdings: Many funds opening a new position, became public on 17 Feb 2026
  • Short interest and volume: Short interest spike, became public on 11 Feb 2026
  • Short interest and volume: Short interest spike, became public on 26 Feb 2026
2025-01-15: 6.3M2025-01-31: 6.6M2025-02-14: 8.5M2025-02-28: 9.4M2025-03-14: 6.7M2025-03-31: 8.3M2025-04-15: 7.0M2025-04-30: 7.5M2025-05-15: 7.9M2025-05-30: 6.5M2025-06-13: 6.2M2025-06-30: 4.9M2025-07-15: 4.5M2025-07-31: 3.3M2025-08-15: 3.0M2025-08-29: 5.3M2025-09-15: 7.3M2025-09-30: 6.5M2025-10-15: 16.7M2025-10-31: 24.1M2025-11-14: 27.5M2025-11-28: 28.2M2025-12-15: 28.6M2025-12-31: 35.6M2026-01-15: 21.4M
The 15 Jan 2026 report against the 24 reports before it. this reportearliernormal: 7.1M
See the evidence (4 changes)

Short interest and volume: Short interest spike became public on 28 Jan 2026

Invivyd had 21.4M shares sold short in the 15 Jan 2026 report, 3.4× the same report last year.

This period
21.4M (the 15 Jan 2026 report)
Normal report (median of 24 earlier)
7.1M
Typical spread (median absolute deviation)
1.6M
How far from its usual level
+6.0
Same report last year
6.3M
History used
1,218 days
2025-01-15: 6.3M2025-01-31: 6.6M2025-02-14: 8.5M2025-02-28: 9.4M2025-03-14: 6.7M2025-03-31: 8.3M2025-04-15: 7.0M2025-04-30: 7.5M2025-05-15: 7.9M2025-05-30: 6.5M2025-06-13: 6.2M2025-06-30: 4.9M2025-07-15: 4.5M2025-07-31: 3.3M2025-08-15: 3.0M2025-08-29: 5.3M2025-09-15: 7.3M2025-09-30: 6.5M2025-10-15: 16.7M2025-10-31: 24.1M2025-11-14: 27.5M2025-11-28: 28.2M2025-12-15: 28.6M2025-12-31: 35.6M2026-01-15: 21.4M
the 15 Jan 2026 report24 earlier reportsnormal: 7.1M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Institutional holdings: Many funds opening a new position became public on 17 Feb 2026

Invivyd saw 46 13F filers open a new position in the quarter ended 31 Dec 2025, 5.1× the same quarter last year.

This period
46 (the quarter ended 31 Dec 2025)
Normal quarter (median of 8 earlier)
15.5
Typical spread (median absolute deviation)
5
How far from its usual level
+4.1
Same quarter last year
9
History used
1,553 days
2023-12-31: 72024-03-31: 292024-06-30: 192024-09-30: 132024-12-31: 92025-03-31: 152025-06-30: 162025-09-30: 232025-12-31: 46
the quarter ended 31 Dec 20258 earlier quartersnormal: 15.5

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

Check it at the source: SEC Form 13F data sets.

Short interest and volume: Short interest spike became public on 11 Feb 2026

Invivyd had 22.3M shares sold short in the 30 Jan 2026 report, 3.4× the same report last year.

This period
22.3M (the 30 Jan 2026 report)
Normal report (median of 24 earlier)
7.4M
Typical spread (median absolute deviation)
2.0M
How far from its usual level
+4.9
Same report last year
6.6M
History used
1,233 days
2025-01-31: 6.6M2025-02-14: 8.5M2025-02-28: 9.4M2025-03-14: 6.7M2025-03-31: 8.3M2025-04-15: 7.0M2025-04-30: 7.5M2025-05-15: 7.9M2025-05-30: 6.5M2025-06-13: 6.2M2025-06-30: 4.9M2025-07-15: 4.5M2025-07-31: 3.3M2025-08-15: 3.0M2025-08-29: 5.3M2025-09-15: 7.3M2025-09-30: 6.5M2025-10-15: 16.7M2025-10-31: 24.1M2025-11-14: 27.5M2025-11-28: 28.2M2025-12-15: 28.6M2025-12-31: 35.6M2026-01-15: 21.4M2026-01-30: 22.3M
the 30 Jan 2026 report24 earlier reportsnormal: 7.4M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 26 Feb 2026

Invivyd had 22.7M shares sold short in the 13 Feb 2026 report, 2.7× the same report last year.

This period
22.7M (the 13 Feb 2026 report)
Normal report (median of 24 earlier)
7.7M
Typical spread (median absolute deviation)
2.6M
How far from its usual level
+3.8
Same report last year
8.5M
History used
1,247 days
2025-02-14: 8.5M2025-02-28: 9.4M2025-03-14: 6.7M2025-03-31: 8.3M2025-04-15: 7.0M2025-04-30: 7.5M2025-05-15: 7.9M2025-05-30: 6.5M2025-06-13: 6.2M2025-06-30: 4.9M2025-07-15: 4.5M2025-07-31: 3.3M2025-08-15: 3.0M2025-08-29: 5.3M2025-09-15: 7.3M2025-09-30: 6.5M2025-10-15: 16.7M2025-10-31: 24.1M2025-11-14: 27.5M2025-11-28: 28.2M2025-12-15: 28.6M2025-12-31: 35.6M2026-01-15: 21.4M2026-01-30: 22.3M2026-02-13: 22.7M
the 13 Feb 2026 report24 earlier reportsnormal: 7.7M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

21 May 2024confirmed

Confirmed across sources Institutional holdings and Lobbying and Short interest and volume

Invivyd (IVVD): saw 29 13F filers open a new position in the quarter ended 31 Mar 2024, 4.8× the same quarter last year; it also lobbying on a new issue; and it had 7.9M shares sold short in the 15 Aug 2024 report, 3.3× the same report last year. Three unrelated kinds of activity within 154 days.

  • Short interest and volume: Short interest spike, became public on 25 Apr 2024
  • Short interest and volume: Short interest spike, became public on 10 May 2024
  • Institutional holdings: Many funds opening a new position, became public on 15 May 2024
  • Short interest and volume: Short interest spike, became public on 25 May 2024
  • Short interest and volume: Short interest spike, became public on 12 Jun 2024
  • Short interest and volume: Short interest spike, became public on 27 Jun 2024
  • Short interest and volume: Short interest spike, became public on 11 Jul 2024
  • Lobbying: Lobbying on a new issue, became public on 18 Jul 2024
  • Short interest and volume: Short interest spike, became public on 25 Jul 2024
  • Short interest and volume: Short interest spike, became public on 10 Aug 2024
  • Short interest and volume: Short interest spike, became public on 27 Aug 2024
  • Short interest and volume: Short interest spike, became public on 12 Sep 2024
  • Short interest and volume: Short interest spike, became public on 25 Sep 2024
2022-03-31: 162022-06-30: 172022-09-30: 112022-12-31: 142023-03-31: 62023-06-30: 102023-09-30: 92023-12-31: 72024-03-31: 29
The quarter ended 31 Mar 2024 against the 8 quarters before it. this quarterearliernormal: 10.5
See the evidence (13 changes)

Short interest and volume: Short interest spike became public on 25 Apr 2024

Invivyd had 4.2M shares sold short in the 15 Apr 2024 report, 1.4× the same report last year.

This period
4.2M (the 15 Apr 2024 report)
Normal report (median of 24 earlier)
2.3M
Typical spread (median absolute deviation)
206K
How far from its usual level
+6.3
Same report last year
3.1M
History used
578 days
2023-04-14: 3.1M2023-04-28: 3.2M2023-05-15: 3.1M2023-05-31: 2.5M2023-06-15: 2.9M2023-06-30: 2.2M2023-07-14: 2.1M2023-07-31: 2.3M2023-08-15: 2.4M2023-08-31: 1.9M2023-09-15: 2.1M2023-09-29: 2.1M2023-10-13: 2.3M2023-10-31: 2.4M2023-11-15: 2.3M2023-11-30: 2.3M2023-12-15: 1.9M2023-12-29: 2.4M2024-01-12: 2.7M2024-01-31: 2.0M2024-02-15: 2.8M2024-02-29: 1.9M2024-03-15: 1.6M2024-03-28: 2.3M2024-04-15: 4.2M
the 15 Apr 2024 report24 earlier reportsnormal: 2.3M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 10 May 2024

Invivyd had 5.9M shares sold short in the 30 Apr 2024 report, 1.9× the same report last year.

This period
5.9M (the 30 Apr 2024 report)
Normal report (median of 24 earlier)
2.3M
Typical spread (median absolute deviation)
206K
How far from its usual level
+11.8
Same report last year
3.2M
History used
593 days
2023-04-28: 3.2M2023-05-15: 3.1M2023-05-31: 2.5M2023-06-15: 2.9M2023-06-30: 2.2M2023-07-14: 2.1M2023-07-31: 2.3M2023-08-15: 2.4M2023-08-31: 1.9M2023-09-15: 2.1M2023-09-29: 2.1M2023-10-13: 2.3M2023-10-31: 2.4M2023-11-15: 2.3M2023-11-30: 2.3M2023-12-15: 1.9M2023-12-29: 2.4M2024-01-12: 2.7M2024-01-31: 2.0M2024-02-15: 2.8M2024-02-29: 1.9M2024-03-15: 1.6M2024-03-28: 2.3M2024-04-15: 4.2M2024-04-30: 5.9M
the 30 Apr 2024 report24 earlier reportsnormal: 2.3M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Institutional holdings: Many funds opening a new position became public on 15 May 2024

Invivyd saw 29 13F filers open a new position in the quarter ended 31 Mar 2024, 4.8× the same quarter last year.

This period
29 (the quarter ended 31 Mar 2024)
Normal quarter (median of 8 earlier)
10.5
Typical spread (median absolute deviation)
3.5
How far from its usual level
+3.6
Same quarter last year
6
History used
913 days
2022-03-31: 162022-06-30: 172022-09-30: 112022-12-31: 142023-03-31: 62023-06-30: 102023-09-30: 92023-12-31: 72024-03-31: 29
the quarter ended 31 Mar 20248 earlier quartersnormal: 10.5

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

Check it at the source: SEC Form 13F data sets.

Short interest and volume: Short interest spike became public on 25 May 2024

Invivyd had 6.2M shares sold short in the 15 May 2024 report, 2.0× the same report last year.

This period
6.2M (the 15 May 2024 report)
Normal report (median of 24 earlier)
2.3M
Typical spread (median absolute deviation)
206K
How far from its usual level
+12.7
Same report last year
3.1M
History used
608 days
2023-05-15: 3.1M2023-05-31: 2.5M2023-06-15: 2.9M2023-06-30: 2.2M2023-07-14: 2.1M2023-07-31: 2.3M2023-08-15: 2.4M2023-08-31: 1.9M2023-09-15: 2.1M2023-09-29: 2.1M2023-10-13: 2.3M2023-10-31: 2.4M2023-11-15: 2.3M2023-11-30: 2.3M2023-12-15: 1.9M2023-12-29: 2.4M2024-01-12: 2.7M2024-01-31: 2.0M2024-02-15: 2.8M2024-02-29: 1.9M2024-03-15: 1.6M2024-03-28: 2.3M2024-04-15: 4.2M2024-04-30: 5.9M2024-05-15: 6.2M
the 15 May 2024 report24 earlier reportsnormal: 2.3M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 12 Jun 2024

Invivyd had 6.9M shares sold short in the 31 May 2024 report, 2.8× the same report last year.

This period
6.9M (the 31 May 2024 report)
Normal report (median of 24 earlier)
2.3M
Typical spread (median absolute deviation)
206K
How far from its usual level
+15.0
Same report last year
2.5M
History used
624 days
2023-05-31: 2.5M2023-06-15: 2.9M2023-06-30: 2.2M2023-07-14: 2.1M2023-07-31: 2.3M2023-08-15: 2.4M2023-08-31: 1.9M2023-09-15: 2.1M2023-09-29: 2.1M2023-10-13: 2.3M2023-10-31: 2.4M2023-11-15: 2.3M2023-11-30: 2.3M2023-12-15: 1.9M2023-12-29: 2.4M2024-01-12: 2.7M2024-01-31: 2.0M2024-02-15: 2.8M2024-02-29: 1.9M2024-03-15: 1.6M2024-03-28: 2.3M2024-04-15: 4.2M2024-04-30: 5.9M2024-05-15: 6.2M2024-05-31: 6.9M
the 31 May 2024 report24 earlier reportsnormal: 2.3M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 27 Jun 2024

Invivyd had 6.8M shares sold short in the 14 Jun 2024 report, 2.3× the same report last year.

This period
6.8M (the 14 Jun 2024 report)
Normal report (median of 24 earlier)
2.3M
Typical spread (median absolute deviation)
277K
How far from its usual level
+10.9
Same report last year
2.9M
History used
638 days
2023-06-15: 2.9M2023-06-30: 2.2M2023-07-14: 2.1M2023-07-31: 2.3M2023-08-15: 2.4M2023-08-31: 1.9M2023-09-15: 2.1M2023-09-29: 2.1M2023-10-13: 2.3M2023-10-31: 2.4M2023-11-15: 2.3M2023-11-30: 2.3M2023-12-15: 1.9M2023-12-29: 2.4M2024-01-12: 2.7M2024-01-31: 2.0M2024-02-15: 2.8M2024-02-29: 1.9M2024-03-15: 1.6M2024-03-28: 2.3M2024-04-15: 4.2M2024-04-30: 5.9M2024-05-15: 6.2M2024-05-31: 6.9M2024-06-14: 6.8M
the 14 Jun 2024 report24 earlier reportsnormal: 2.3M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 11 Jul 2024

Invivyd had 7.1M shares sold short in the 28 Jun 2024 report, 3.2× the same report last year.

This period
7.1M (the 28 Jun 2024 report)
Normal report (median of 24 earlier)
2.3M
Typical spread (median absolute deviation)
277K
How far from its usual level
+11.6
Same report last year
2.2M
History used
652 days
2023-06-30: 2.2M2023-07-14: 2.1M2023-07-31: 2.3M2023-08-15: 2.4M2023-08-31: 1.9M2023-09-15: 2.1M2023-09-29: 2.1M2023-10-13: 2.3M2023-10-31: 2.4M2023-11-15: 2.3M2023-11-30: 2.3M2023-12-15: 1.9M2023-12-29: 2.4M2024-01-12: 2.7M2024-01-31: 2.0M2024-02-15: 2.8M2024-02-29: 1.9M2024-03-15: 1.6M2024-03-28: 2.3M2024-04-15: 4.2M2024-04-30: 5.9M2024-05-15: 6.2M2024-05-31: 6.9M2024-06-14: 6.8M2024-06-28: 7.1M
the 28 Jun 2024 report24 earlier reportsnormal: 2.3M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Lobbying: Lobbying on a new issue became public on 18 Jul 2024

Invivyd lobbying on a new issue.

New
['BUD', 'DIS']
Rule
only points whose every posting (and value revision) is at or before as_of
Field
issue_codes
Metric
lobbying.filings_count
Point id
6410097

Short interest and volume: Short interest spike became public on 25 Jul 2024

Invivyd had 7.6M shares sold short in the 15 Jul 2024 report, 3.6× the same report last year.

This period
7.6M (the 15 Jul 2024 report)
Normal report (median of 24 earlier)
2.3M
Typical spread (median absolute deviation)
358K
How far from its usual level
+10.0
Same report last year
2.1M
History used
669 days
2023-07-14: 2.1M2023-07-31: 2.3M2023-08-15: 2.4M2023-08-31: 1.9M2023-09-15: 2.1M2023-09-29: 2.1M2023-10-13: 2.3M2023-10-31: 2.4M2023-11-15: 2.3M2023-11-30: 2.3M2023-12-15: 1.9M2023-12-29: 2.4M2024-01-12: 2.7M2024-01-31: 2.0M2024-02-15: 2.8M2024-02-29: 1.9M2024-03-15: 1.6M2024-03-28: 2.3M2024-04-15: 4.2M2024-04-30: 5.9M2024-05-15: 6.2M2024-05-31: 6.9M2024-06-14: 6.8M2024-06-28: 7.1M2024-07-15: 7.6M
the 15 Jul 2024 report24 earlier reportsnormal: 2.3M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 10 Aug 2024

Invivyd had 7.8M shares sold short in the 31 Jul 2024 report, 3.4× the same report last year.

This period
7.8M (the 31 Jul 2024 report)
Normal report (median of 24 earlier)
2.4M
Typical spread (median absolute deviation)
385K
How far from its usual level
+9.5
Same report last year
2.3M
History used
685 days
2023-07-31: 2.3M2023-08-15: 2.4M2023-08-31: 1.9M2023-09-15: 2.1M2023-09-29: 2.1M2023-10-13: 2.3M2023-10-31: 2.4M2023-11-15: 2.3M2023-11-30: 2.3M2023-12-15: 1.9M2023-12-29: 2.4M2024-01-12: 2.7M2024-01-31: 2.0M2024-02-15: 2.8M2024-02-29: 1.9M2024-03-15: 1.6M2024-03-28: 2.3M2024-04-15: 4.2M2024-04-30: 5.9M2024-05-15: 6.2M2024-05-31: 6.9M2024-06-14: 6.8M2024-06-28: 7.1M2024-07-15: 7.6M2024-07-31: 7.8M
the 31 Jul 2024 report24 earlier reportsnormal: 2.4M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 27 Aug 2024

Invivyd had 7.9M shares sold short in the 15 Aug 2024 report, 3.3× the same report last year.

This period
7.9M (the 15 Aug 2024 report)
Normal report (median of 24 earlier)
2.4M
Typical spread (median absolute deviation)
415K
How far from its usual level
+9.0
Same report last year
2.4M
History used
700 days
2023-08-15: 2.4M2023-08-31: 1.9M2023-09-15: 2.1M2023-09-29: 2.1M2023-10-13: 2.3M2023-10-31: 2.4M2023-11-15: 2.3M2023-11-30: 2.3M2023-12-15: 1.9M2023-12-29: 2.4M2024-01-12: 2.7M2024-01-31: 2.0M2024-02-15: 2.8M2024-02-29: 1.9M2024-03-15: 1.6M2024-03-28: 2.3M2024-04-15: 4.2M2024-04-30: 5.9M2024-05-15: 6.2M2024-05-31: 6.9M2024-06-14: 6.8M2024-06-28: 7.1M2024-07-15: 7.6M2024-07-31: 7.8M2024-08-15: 7.9M
the 15 Aug 2024 report24 earlier reportsnormal: 2.4M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 12 Sep 2024

Invivyd had 7.6M shares sold short in the 30 Aug 2024 report, 3.9× the same report last year.

This period
7.6M (the 30 Aug 2024 report)
Normal report (median of 24 earlier)
2.4M
Typical spread (median absolute deviation)
468K
How far from its usual level
+7.6
Same report last year
1.9M
History used
715 days
2023-08-31: 1.9M2023-09-15: 2.1M2023-09-29: 2.1M2023-10-13: 2.3M2023-10-31: 2.4M2023-11-15: 2.3M2023-11-30: 2.3M2023-12-15: 1.9M2023-12-29: 2.4M2024-01-12: 2.7M2024-01-31: 2.0M2024-02-15: 2.8M2024-02-29: 1.9M2024-03-15: 1.6M2024-03-28: 2.3M2024-04-15: 4.2M2024-04-30: 5.9M2024-05-15: 6.2M2024-05-31: 6.9M2024-06-14: 6.8M2024-06-28: 7.1M2024-07-15: 7.6M2024-07-31: 7.8M2024-08-15: 7.9M2024-08-30: 7.6M
the 30 Aug 2024 report24 earlier reportsnormal: 2.4M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 25 Sep 2024

Invivyd had 7.4M shares sold short in the 13 Sep 2024 report, 3.5× the same report last year.

This period
7.4M (the 13 Sep 2024 report)
Normal report (median of 24 earlier)
2.6M
Typical spread (median absolute deviation)
673K
How far from its usual level
+4.8
Same report last year
2.1M
History used
729 days
2023-09-15: 2.1M2023-09-29: 2.1M2023-10-13: 2.3M2023-10-31: 2.4M2023-11-15: 2.3M2023-11-30: 2.3M2023-12-15: 1.9M2023-12-29: 2.4M2024-01-12: 2.7M2024-01-31: 2.0M2024-02-15: 2.8M2024-02-29: 1.9M2024-03-15: 1.6M2024-03-28: 2.3M2024-04-15: 4.2M2024-04-30: 5.9M2024-05-15: 6.2M2024-05-31: 6.9M2024-06-14: 6.8M2024-06-28: 7.1M2024-07-15: 7.6M2024-07-31: 7.8M2024-08-15: 7.9M2024-08-30: 7.6M2024-09-13: 7.4M
the 13 Sep 2024 report24 earlier reportsnormal: 2.6M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

Timeline

Changes and notable records, by the date each became public

  1. 1 Sep 2026Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  2. 1 Sep 2026Filings record

    Director or officer change

  3. 24 Jul 2026Filings record

    Delisting notice or listing transfer

  4. 20 Jul 2026Lobbying change

    lobbying on a new issue.

    See the evidence
    New
    ['MAN']
    Rule
    only points whose every posting (and value revision) is at or before as_of
    Field
    issue_codes
    Metric
    lobbying.filings_count
    Point id
    4555123
  5. 28 Apr 2026Lobbying record

    INVIVYD, INC.: lobbying engagement terminated (KING & SPALDING LLP)

  6. 26 Feb 2026Short interest and volume change

    had 22.7M shares sold short in the 13 Feb 2026 report, 2.7× the same report last year.

    Same report last year: 8.5M; its normal report is 7.7M.

    See the evidence
    This period
    22.7M (the 13 Feb 2026 report)
    Normal report (median of 24 earlier)
    7.7M
    Typical spread (median absolute deviation)
    2.6M
    How far from its usual level
    +3.8
    Same report last year
    8.5M
    History used
    1,247 days
    2025-02-14: 8.5M2025-02-28: 9.4M2025-03-14: 6.7M2025-03-31: 8.3M2025-04-15: 7.0M2025-04-30: 7.5M2025-05-15: 7.9M2025-05-30: 6.5M2025-06-13: 6.2M2025-06-30: 4.9M2025-07-15: 4.5M2025-07-31: 3.3M2025-08-15: 3.0M2025-08-29: 5.3M2025-09-15: 7.3M2025-09-30: 6.5M2025-10-15: 16.7M2025-10-31: 24.1M2025-11-14: 27.5M2025-11-28: 28.2M2025-12-15: 28.6M2025-12-31: 35.6M2026-01-15: 21.4M2026-01-30: 22.3M2026-02-13: 22.7M
    the 13 Feb 2026 report24 earlier reportsnormal: 7.7M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  7. 17 Feb 2026several at once

    had 21.4M shares sold short in the 15 Jan 2026 report, 3.4× the same report last year, while it saw 46 13F filers open a new position in the quarter ended 31 Dec 2025, 5.1× the same quarter last year. Two unrelated kinds of activity within 28 days.

    See the evidence (4 changes)

    Short interest and volume: Short interest spike became public on 28 Jan 2026

    Invivyd had 21.4M shares sold short in the 15 Jan 2026 report, 3.4× the same report last year.

    This period
    21.4M (the 15 Jan 2026 report)
    Normal report (median of 24 earlier)
    7.1M
    Typical spread (median absolute deviation)
    1.6M
    How far from its usual level
    +6.0
    Same report last year
    6.3M
    History used
    1,218 days
    2025-01-15: 6.3M2025-01-31: 6.6M2025-02-14: 8.5M2025-02-28: 9.4M2025-03-14: 6.7M2025-03-31: 8.3M2025-04-15: 7.0M2025-04-30: 7.5M2025-05-15: 7.9M2025-05-30: 6.5M2025-06-13: 6.2M2025-06-30: 4.9M2025-07-15: 4.5M2025-07-31: 3.3M2025-08-15: 3.0M2025-08-29: 5.3M2025-09-15: 7.3M2025-09-30: 6.5M2025-10-15: 16.7M2025-10-31: 24.1M2025-11-14: 27.5M2025-11-28: 28.2M2025-12-15: 28.6M2025-12-31: 35.6M2026-01-15: 21.4M
    the 15 Jan 2026 report24 earlier reportsnormal: 7.1M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Institutional holdings: Many funds opening a new position became public on 17 Feb 2026

    Invivyd saw 46 13F filers open a new position in the quarter ended 31 Dec 2025, 5.1× the same quarter last year.

    This period
    46 (the quarter ended 31 Dec 2025)
    Normal quarter (median of 8 earlier)
    15.5
    Typical spread (median absolute deviation)
    5
    How far from its usual level
    +4.1
    Same quarter last year
    9
    History used
    1,553 days
    2023-12-31: 72024-03-31: 292024-06-30: 192024-09-30: 132024-12-31: 92025-03-31: 152025-06-30: 162025-09-30: 232025-12-31: 46
    the quarter ended 31 Dec 20258 earlier quartersnormal: 15.5

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

    Check it at the source: SEC Form 13F data sets.

    Short interest and volume: Short interest spike became public on 11 Feb 2026

    Invivyd had 22.3M shares sold short in the 30 Jan 2026 report, 3.4× the same report last year.

    This period
    22.3M (the 30 Jan 2026 report)
    Normal report (median of 24 earlier)
    7.4M
    Typical spread (median absolute deviation)
    2.0M
    How far from its usual level
    +4.9
    Same report last year
    6.6M
    History used
    1,233 days
    2025-01-31: 6.6M2025-02-14: 8.5M2025-02-28: 9.4M2025-03-14: 6.7M2025-03-31: 8.3M2025-04-15: 7.0M2025-04-30: 7.5M2025-05-15: 7.9M2025-05-30: 6.5M2025-06-13: 6.2M2025-06-30: 4.9M2025-07-15: 4.5M2025-07-31: 3.3M2025-08-15: 3.0M2025-08-29: 5.3M2025-09-15: 7.3M2025-09-30: 6.5M2025-10-15: 16.7M2025-10-31: 24.1M2025-11-14: 27.5M2025-11-28: 28.2M2025-12-15: 28.6M2025-12-31: 35.6M2026-01-15: 21.4M2026-01-30: 22.3M
    the 30 Jan 2026 report24 earlier reportsnormal: 7.4M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Short interest and volume: Short interest spike became public on 26 Feb 2026

    Invivyd had 22.7M shares sold short in the 13 Feb 2026 report, 2.7× the same report last year.

    This period
    22.7M (the 13 Feb 2026 report)
    Normal report (median of 24 earlier)
    7.7M
    Typical spread (median absolute deviation)
    2.6M
    How far from its usual level
    +3.8
    Same report last year
    8.5M
    History used
    1,247 days
    2025-02-14: 8.5M2025-02-28: 9.4M2025-03-14: 6.7M2025-03-31: 8.3M2025-04-15: 7.0M2025-04-30: 7.5M2025-05-15: 7.9M2025-05-30: 6.5M2025-06-13: 6.2M2025-06-30: 4.9M2025-07-15: 4.5M2025-07-31: 3.3M2025-08-15: 3.0M2025-08-29: 5.3M2025-09-15: 7.3M2025-09-30: 6.5M2025-10-15: 16.7M2025-10-31: 24.1M2025-11-14: 27.5M2025-11-28: 28.2M2025-12-15: 28.6M2025-12-31: 35.6M2026-01-15: 21.4M2026-01-30: 22.3M2026-02-13: 22.7M
    the 13 Feb 2026 report24 earlier reportsnormal: 7.7M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

  8. 17 Feb 2026Institutional holdings change

    saw 46 13F filers open a new position in the quarter ended 31 Dec 2025, 5.1× the same quarter last year.

    Same quarter last year: 9; its normal quarter is 15.5.

    See the evidence
    This period
    46 (the quarter ended 31 Dec 2025)
    Normal quarter (median of 8 earlier)
    15.5
    Typical spread (median absolute deviation)
    5
    How far from its usual level
    +4.1
    Same quarter last year
    9
    History used
    1,553 days
    2023-12-31: 72024-03-31: 292024-06-30: 192024-09-30: 132024-12-31: 92025-03-31: 152025-06-30: 162025-09-30: 232025-12-31: 46
    the quarter ended 31 Dec 20258 earlier quartersnormal: 15.5

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

    Check it at the source: SEC Form 13F data sets.

  9. 11 Feb 2026Short interest and volume change

    had 22.3M shares sold short in the 30 Jan 2026 report, 3.4× the same report last year.

    Same report last year: 6.6M; its normal report is 7.4M.

    See the evidence
    This period
    22.3M (the 30 Jan 2026 report)
    Normal report (median of 24 earlier)
    7.4M
    Typical spread (median absolute deviation)
    2.0M
    How far from its usual level
    +4.9
    Same report last year
    6.6M
    History used
    1,233 days
    2025-01-31: 6.6M2025-02-14: 8.5M2025-02-28: 9.4M2025-03-14: 6.7M2025-03-31: 8.3M2025-04-15: 7.0M2025-04-30: 7.5M2025-05-15: 7.9M2025-05-30: 6.5M2025-06-13: 6.2M2025-06-30: 4.9M2025-07-15: 4.5M2025-07-31: 3.3M2025-08-15: 3.0M2025-08-29: 5.3M2025-09-15: 7.3M2025-09-30: 6.5M2025-10-15: 16.7M2025-10-31: 24.1M2025-11-14: 27.5M2025-11-28: 28.2M2025-12-15: 28.6M2025-12-31: 35.6M2026-01-15: 21.4M2026-01-30: 22.3M
    the 30 Jan 2026 report24 earlier reportsnormal: 7.4M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  10. 28 Jan 2026Short interest and volume change

    had 21.4M shares sold short in the 15 Jan 2026 report, 3.4× the same report last year.

    Same report last year: 6.3M; its normal report is 7.1M.

    See the evidence
    This period
    21.4M (the 15 Jan 2026 report)
    Normal report (median of 24 earlier)
    7.1M
    Typical spread (median absolute deviation)
    1.6M
    How far from its usual level
    +6.0
    Same report last year
    6.3M
    History used
    1,218 days
    2025-01-15: 6.3M2025-01-31: 6.6M2025-02-14: 8.5M2025-02-28: 9.4M2025-03-14: 6.7M2025-03-31: 8.3M2025-04-15: 7.0M2025-04-30: 7.5M2025-05-15: 7.9M2025-05-30: 6.5M2025-06-13: 6.2M2025-06-30: 4.9M2025-07-15: 4.5M2025-07-31: 3.3M2025-08-15: 3.0M2025-08-29: 5.3M2025-09-15: 7.3M2025-09-30: 6.5M2025-10-15: 16.7M2025-10-31: 24.1M2025-11-14: 27.5M2025-11-28: 28.2M2025-12-15: 28.6M2025-12-31: 35.6M2026-01-15: 21.4M
    the 15 Jan 2026 report24 earlier reportsnormal: 7.1M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  11. 23 Jan 2026Lobbying record

    INVIVYD, INC.: new lobbying registration (KING & SPALDING LLP) (dated 5 Jan 2026)

  12. 13 Jan 2026Short interest and volume change

    had 35.6M shares sold short in the 31 Dec 2025 report, 8.9× the same report last year.

    Same report last year: 4.0M; its normal report is 6.8M.

    See the evidence
    This period
    35.6M (the 31 Dec 2025 report)
    Normal report (median of 24 earlier)
    6.8M
    Typical spread (median absolute deviation)
    1.6M
    How far from its usual level
    +12.0
    Same report last year
    4.0M
    History used
    1,203 days
    2024-12-31: 4.0M2025-01-15: 6.3M2025-01-31: 6.6M2025-02-14: 8.5M2025-02-28: 9.4M2025-03-14: 6.7M2025-03-31: 8.3M2025-04-15: 7.0M2025-04-30: 7.5M2025-05-15: 7.9M2025-05-30: 6.5M2025-06-13: 6.2M2025-06-30: 4.9M2025-07-15: 4.5M2025-07-31: 3.3M2025-08-15: 3.0M2025-08-29: 5.3M2025-09-15: 7.3M2025-09-30: 6.5M2025-10-15: 16.7M2025-10-31: 24.1M2025-11-14: 27.5M2025-11-28: 28.2M2025-12-15: 28.6M2025-12-31: 35.6M
    the 31 Dec 2025 report24 earlier reportsnormal: 6.8M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  13. 25 Dec 2025Short interest and volume change

    had 28.6M shares sold short in the 15 Dec 2025 report, 7.8× the same report last year.

    Same report last year: 3.7M; its normal report is 6.6M.

    See the evidence
    This period
    28.6M (the 15 Dec 2025 report)
    Normal report (median of 24 earlier)
    6.6M
    Typical spread (median absolute deviation)
    1.7M
    How far from its usual level
    +8.9
    Same report last year
    3.7M
    History used
    1,187 days
    2024-12-13: 3.7M2024-12-31: 4.0M2025-01-15: 6.3M2025-01-31: 6.6M2025-02-14: 8.5M2025-02-28: 9.4M2025-03-14: 6.7M2025-03-31: 8.3M2025-04-15: 7.0M2025-04-30: 7.5M2025-05-15: 7.9M2025-05-30: 6.5M2025-06-13: 6.2M2025-06-30: 4.9M2025-07-15: 4.5M2025-07-31: 3.3M2025-08-15: 3.0M2025-08-29: 5.3M2025-09-15: 7.3M2025-09-30: 6.5M2025-10-15: 16.7M2025-10-31: 24.1M2025-11-14: 27.5M2025-11-28: 28.2M2025-12-15: 28.6M
    the 15 Dec 2025 report24 earlier reportsnormal: 6.6M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  14. 19 Dec 2025Lobbying record

    INVIVYD: new lobbying registration (FORBES-TATE) (dated 10 Dec 2025)

  15. 10 Dec 2025Short interest and volume change

    had 28.2M shares sold short in the 28 Nov 2025 report, 5.8× the same report last year.

    Same report last year: 4.9M; its normal report is 6.6M.

    See the evidence
    This period
    28.2M (the 28 Nov 2025 report)
    Normal report (median of 24 earlier)
    6.6M
    Typical spread (median absolute deviation)
    1.7M
    How far from its usual level
    +8.8
    Same report last year
    4.9M
    History used
    1,170 days
    2024-11-29: 4.9M2024-12-13: 3.7M2024-12-31: 4.0M2025-01-15: 6.3M2025-01-31: 6.6M2025-02-14: 8.5M2025-02-28: 9.4M2025-03-14: 6.7M2025-03-31: 8.3M2025-04-15: 7.0M2025-04-30: 7.5M2025-05-15: 7.9M2025-05-30: 6.5M2025-06-13: 6.2M2025-06-30: 4.9M2025-07-15: 4.5M2025-07-31: 3.3M2025-08-15: 3.0M2025-08-29: 5.3M2025-09-15: 7.3M2025-09-30: 6.5M2025-10-15: 16.7M2025-10-31: 24.1M2025-11-14: 27.5M2025-11-28: 28.2M
    the 28 Nov 2025 report24 earlier reportsnormal: 6.6M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  16. 26 Nov 2025Short interest and volume change

    had 27.5M shares sold short in the 14 Nov 2025 report, 4.1× the same report last year.

    Same report last year: 6.7M; its normal report is 6.6M.

    See the evidence
    This period
    27.5M (the 14 Nov 2025 report)
    Normal report (median of 24 earlier)
    6.6M
    Typical spread (median absolute deviation)
    1.5M
    How far from its usual level
    +9.5
    Same report last year
    6.7M
    History used
    1,156 days
    2024-11-15: 6.7M2024-11-29: 4.9M2024-12-13: 3.7M2024-12-31: 4.0M2025-01-15: 6.3M2025-01-31: 6.6M2025-02-14: 8.5M2025-02-28: 9.4M2025-03-14: 6.7M2025-03-31: 8.3M2025-04-15: 7.0M2025-04-30: 7.5M2025-05-15: 7.9M2025-05-30: 6.5M2025-06-13: 6.2M2025-06-30: 4.9M2025-07-15: 4.5M2025-07-31: 3.3M2025-08-15: 3.0M2025-08-29: 5.3M2025-09-15: 7.3M2025-09-30: 6.5M2025-10-15: 16.7M2025-10-31: 24.1M2025-11-14: 27.5M
    the 14 Nov 2025 report24 earlier reportsnormal: 6.6M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  17. 21 Nov 2025Insiders record

    MCLAUGHLIN KEVIN F (director) bought 50,000 shares of IVVD ($125,000) (dated 20 Nov 2025)

  18. 13 Nov 2025Short interest and volume change

    had 24.1M shares sold short in the 31 Oct 2025 report, 2.9× the same report last year.

    Same report last year: 8.3M; its normal report is 6.6M.

    See the evidence
    This period
    24.1M (the 31 Oct 2025 report)
    Normal report (median of 24 earlier)
    6.6M
    Typical spread (median absolute deviation)
    1.5M
    How far from its usual level
    +7.9
    Same report last year
    8.3M
    History used
    1,142 days
    2024-10-31: 8.3M2024-11-15: 6.7M2024-11-29: 4.9M2024-12-13: 3.7M2024-12-31: 4.0M2025-01-15: 6.3M2025-01-31: 6.6M2025-02-14: 8.5M2025-02-28: 9.4M2025-03-14: 6.7M2025-03-31: 8.3M2025-04-15: 7.0M2025-04-30: 7.5M2025-05-15: 7.9M2025-05-30: 6.5M2025-06-13: 6.2M2025-06-30: 4.9M2025-07-15: 4.5M2025-07-31: 3.3M2025-08-15: 3.0M2025-08-29: 5.3M2025-09-15: 7.3M2025-09-30: 6.5M2025-10-15: 16.7M2025-10-31: 24.1M
    the 31 Oct 2025 report24 earlier reportsnormal: 6.6M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  19. 25 Oct 2025Short interest and volume change

    had 16.7M shares sold short in the 15 Oct 2025 report, 2.3× the same report last year.

    Same report last year: 7.1M; its normal report is 6.6M.

    See the evidence
    This period
    16.7M (the 15 Oct 2025 report)
    Normal report (median of 24 earlier)
    6.6M
    Typical spread (median absolute deviation)
    1.3M
    How far from its usual level
    +5.2
    Same report last year
    7.1M
    History used
    1,126 days
    2024-10-15: 7.1M2024-10-31: 8.3M2024-11-15: 6.7M2024-11-29: 4.9M2024-12-13: 3.7M2024-12-31: 4.0M2025-01-15: 6.3M2025-01-31: 6.6M2025-02-14: 8.5M2025-02-28: 9.4M2025-03-14: 6.7M2025-03-31: 8.3M2025-04-15: 7.0M2025-04-30: 7.5M2025-05-15: 7.9M2025-05-30: 6.5M2025-06-13: 6.2M2025-06-30: 4.9M2025-07-15: 4.5M2025-07-31: 3.3M2025-08-15: 3.0M2025-08-29: 5.3M2025-09-15: 7.3M2025-09-30: 6.5M2025-10-15: 16.7M
    the 15 Oct 2025 report24 earlier reportsnormal: 6.6M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  20. 24 Sep 2025Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  21. 24 Sep 2025Filings record

    Director or officer change

  22. 19 Aug 2025Financials change

    reported revenue of $11.8M for the quarter ended 30 Jun 2025, 5.2× the same quarter last year.

    Same quarter last year: $2.3M; its normal quarter is $1.1M.

    See the evidence
    This period
    $11.8M (the quarter ended 30 Jun 2025)
    Normal quarter (median of 8 earlier)
    $1.1M
    Typical spread (median absolute deviation)
    $1.1M
    How far from its usual level
    +6.3
    Same quarter last year
    $2.3M
    History used
    731 days
    2023-06-30: $02023-09-30: $02023-12-31: $02024-03-31: $02024-06-30: $2.3M2024-09-30: $9.3M2024-12-31: $13.8M2025-03-31: $11.3M2025-06-30: $11.8M
    the quarter ended 30 Jun 20258 earlier quartersnormal: $1.1M

    Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.

    Check it at the source: SEC EDGAR quarterly reports.

  23. 20 May 2025Financials change

    reported revenue of $11.3M for the quarter ended 31 Mar 2025, against none in the same quarter last year.

    See the evidence
    This period
    $11.3M (the quarter ended 31 Mar 2025)
    Normal quarter (median of 7 earlier)
    $0
    Typical spread (median absolute deviation)
    $0
    How far from its usual level
    +11.3
    Same quarter last year
    $0
    History used
    640 days
    2023-06-30: $02023-09-30: $02023-12-31: $02024-03-31: $02024-06-30: $2.3M2024-09-30: $9.3M2024-12-31: $13.8M2025-03-31: $11.3M
    the quarter ended 31 Mar 20257 earlier quartersnormal: $0

    Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.

    Check it at the source: SEC EDGAR quarterly reports.

  24. 25 Apr 2025Filings record

    Delisting notice or listing transfer

  25. 26 Mar 2025Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  26. 26 Mar 2025Filings record

    Director or officer change

  27. 27 Dec 2024Filings record

    Delisting notice or listing transfer

  28. 2 Dec 2024Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  29. 2 Dec 2024Filings record

    Director or officer change

  30. 7 Nov 2024Lobbying record

    INVIVYD, INC.: lobbying engagement terminated (EAST END GROUP, LLC) (dated 1 Aug 2024)

  31. 25 Sep 2024Short interest and volume change

    had 7.4M shares sold short in the 13 Sep 2024 report, 3.5× the same report last year.

    Same report last year: 2.1M; its normal report is 2.6M.

    See the evidence
    This period
    7.4M (the 13 Sep 2024 report)
    Normal report (median of 24 earlier)
    2.6M
    Typical spread (median absolute deviation)
    673K
    How far from its usual level
    +4.8
    Same report last year
    2.1M
    History used
    729 days
    2023-09-15: 2.1M2023-09-29: 2.1M2023-10-13: 2.3M2023-10-31: 2.4M2023-11-15: 2.3M2023-11-30: 2.3M2023-12-15: 1.9M2023-12-29: 2.4M2024-01-12: 2.7M2024-01-31: 2.0M2024-02-15: 2.8M2024-02-29: 1.9M2024-03-15: 1.6M2024-03-28: 2.3M2024-04-15: 4.2M2024-04-30: 5.9M2024-05-15: 6.2M2024-05-31: 6.9M2024-06-14: 6.8M2024-06-28: 7.1M2024-07-15: 7.6M2024-07-31: 7.8M2024-08-15: 7.9M2024-08-30: 7.6M2024-09-13: 7.4M
    the 13 Sep 2024 report24 earlier reportsnormal: 2.6M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  32. 12 Sep 2024Short interest and volume change

    had 7.6M shares sold short in the 30 Aug 2024 report, 3.9× the same report last year.

    Same report last year: 1.9M; its normal report is 2.4M.

    See the evidence
    This period
    7.6M (the 30 Aug 2024 report)
    Normal report (median of 24 earlier)
    2.4M
    Typical spread (median absolute deviation)
    468K
    How far from its usual level
    +7.6
    Same report last year
    1.9M
    History used
    715 days
    2023-08-31: 1.9M2023-09-15: 2.1M2023-09-29: 2.1M2023-10-13: 2.3M2023-10-31: 2.4M2023-11-15: 2.3M2023-11-30: 2.3M2023-12-15: 1.9M2023-12-29: 2.4M2024-01-12: 2.7M2024-01-31: 2.0M2024-02-15: 2.8M2024-02-29: 1.9M2024-03-15: 1.6M2024-03-28: 2.3M2024-04-15: 4.2M2024-04-30: 5.9M2024-05-15: 6.2M2024-05-31: 6.9M2024-06-14: 6.8M2024-06-28: 7.1M2024-07-15: 7.6M2024-07-31: 7.8M2024-08-15: 7.9M2024-08-30: 7.6M
    the 30 Aug 2024 report24 earlier reportsnormal: 2.4M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  33. 27 Aug 2024Short interest and volume change

    had 7.9M shares sold short in the 15 Aug 2024 report, 3.3× the same report last year.

    Same report last year: 2.4M; its normal report is 2.4M.

    See the evidence
    This period
    7.9M (the 15 Aug 2024 report)
    Normal report (median of 24 earlier)
    2.4M
    Typical spread (median absolute deviation)
    415K
    How far from its usual level
    +9.0
    Same report last year
    2.4M
    History used
    700 days
    2023-08-15: 2.4M2023-08-31: 1.9M2023-09-15: 2.1M2023-09-29: 2.1M2023-10-13: 2.3M2023-10-31: 2.4M2023-11-15: 2.3M2023-11-30: 2.3M2023-12-15: 1.9M2023-12-29: 2.4M2024-01-12: 2.7M2024-01-31: 2.0M2024-02-15: 2.8M2024-02-29: 1.9M2024-03-15: 1.6M2024-03-28: 2.3M2024-04-15: 4.2M2024-04-30: 5.9M2024-05-15: 6.2M2024-05-31: 6.9M2024-06-14: 6.8M2024-06-28: 7.1M2024-07-15: 7.6M2024-07-31: 7.8M2024-08-15: 7.9M
    the 15 Aug 2024 report24 earlier reportsnormal: 2.4M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  34. 10 Aug 2024Short interest and volume change

    had 7.8M shares sold short in the 31 Jul 2024 report, 3.4× the same report last year.

    Same report last year: 2.3M; its normal report is 2.4M.

    See the evidence
    This period
    7.8M (the 31 Jul 2024 report)
    Normal report (median of 24 earlier)
    2.4M
    Typical spread (median absolute deviation)
    385K
    How far from its usual level
    +9.5
    Same report last year
    2.3M
    History used
    685 days
    2023-07-31: 2.3M2023-08-15: 2.4M2023-08-31: 1.9M2023-09-15: 2.1M2023-09-29: 2.1M2023-10-13: 2.3M2023-10-31: 2.4M2023-11-15: 2.3M2023-11-30: 2.3M2023-12-15: 1.9M2023-12-29: 2.4M2024-01-12: 2.7M2024-01-31: 2.0M2024-02-15: 2.8M2024-02-29: 1.9M2024-03-15: 1.6M2024-03-28: 2.3M2024-04-15: 4.2M2024-04-30: 5.9M2024-05-15: 6.2M2024-05-31: 6.9M2024-06-14: 6.8M2024-06-28: 7.1M2024-07-15: 7.6M2024-07-31: 7.8M
    the 31 Jul 2024 report24 earlier reportsnormal: 2.4M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  35. 25 Jul 2024Short interest and volume change

    had 7.6M shares sold short in the 15 Jul 2024 report, 3.6× the same report last year.

    Same report last year: 2.1M; its normal report is 2.3M.

    See the evidence
    This period
    7.6M (the 15 Jul 2024 report)
    Normal report (median of 24 earlier)
    2.3M
    Typical spread (median absolute deviation)
    358K
    How far from its usual level
    +10.0
    Same report last year
    2.1M
    History used
    669 days
    2023-07-14: 2.1M2023-07-31: 2.3M2023-08-15: 2.4M2023-08-31: 1.9M2023-09-15: 2.1M2023-09-29: 2.1M2023-10-13: 2.3M2023-10-31: 2.4M2023-11-15: 2.3M2023-11-30: 2.3M2023-12-15: 1.9M2023-12-29: 2.4M2024-01-12: 2.7M2024-01-31: 2.0M2024-02-15: 2.8M2024-02-29: 1.9M2024-03-15: 1.6M2024-03-28: 2.3M2024-04-15: 4.2M2024-04-30: 5.9M2024-05-15: 6.2M2024-05-31: 6.9M2024-06-14: 6.8M2024-06-28: 7.1M2024-07-15: 7.6M
    the 15 Jul 2024 report24 earlier reportsnormal: 2.3M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  36. 18 Jul 2024Lobbying change

    lobbying on a new issue.

    See the evidence
    New
    ['BUD', 'DIS']
    Rule
    only points whose every posting (and value revision) is at or before as_of
    Field
    issue_codes
    Metric
    lobbying.filings_count
    Point id
    6410097
  37. 11 Jul 2024Short interest and volume change

    had 7.1M shares sold short in the 28 Jun 2024 report, 3.2× the same report last year.

    Same report last year: 2.2M; its normal report is 2.3M.

    See the evidence
    This period
    7.1M (the 28 Jun 2024 report)
    Normal report (median of 24 earlier)
    2.3M
    Typical spread (median absolute deviation)
    277K
    How far from its usual level
    +11.6
    Same report last year
    2.2M
    History used
    652 days
    2023-06-30: 2.2M2023-07-14: 2.1M2023-07-31: 2.3M2023-08-15: 2.4M2023-08-31: 1.9M2023-09-15: 2.1M2023-09-29: 2.1M2023-10-13: 2.3M2023-10-31: 2.4M2023-11-15: 2.3M2023-11-30: 2.3M2023-12-15: 1.9M2023-12-29: 2.4M2024-01-12: 2.7M2024-01-31: 2.0M2024-02-15: 2.8M2024-02-29: 1.9M2024-03-15: 1.6M2024-03-28: 2.3M2024-04-15: 4.2M2024-04-30: 5.9M2024-05-15: 6.2M2024-05-31: 6.9M2024-06-14: 6.8M2024-06-28: 7.1M
    the 28 Jun 2024 report24 earlier reportsnormal: 2.3M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  38. 3 Jul 2024Lobbying record

    INVIVYD, INC.: lobbying engagement terminated (CGCN GROUP, LLC) (dated 30 Jun 2024)

  39. 27 Jun 2024Short interest and volume change

    had 6.8M shares sold short in the 14 Jun 2024 report, 2.3× the same report last year.

    Same report last year: 2.9M; its normal report is 2.3M.

    See the evidence
    This period
    6.8M (the 14 Jun 2024 report)
    Normal report (median of 24 earlier)
    2.3M
    Typical spread (median absolute deviation)
    277K
    How far from its usual level
    +10.9
    Same report last year
    2.9M
    History used
    638 days
    2023-06-15: 2.9M2023-06-30: 2.2M2023-07-14: 2.1M2023-07-31: 2.3M2023-08-15: 2.4M2023-08-31: 1.9M2023-09-15: 2.1M2023-09-29: 2.1M2023-10-13: 2.3M2023-10-31: 2.4M2023-11-15: 2.3M2023-11-30: 2.3M2023-12-15: 1.9M2023-12-29: 2.4M2024-01-12: 2.7M2024-01-31: 2.0M2024-02-15: 2.8M2024-02-29: 1.9M2024-03-15: 1.6M2024-03-28: 2.3M2024-04-15: 4.2M2024-04-30: 5.9M2024-05-15: 6.2M2024-05-31: 6.9M2024-06-14: 6.8M
    the 14 Jun 2024 report24 earlier reportsnormal: 2.3M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  40. 12 Jun 2024Short interest and volume change

    had 6.9M shares sold short in the 31 May 2024 report, 2.8× the same report last year.

    Same report last year: 2.5M; its normal report is 2.3M.

    See the evidence
    This period
    6.9M (the 31 May 2024 report)
    Normal report (median of 24 earlier)
    2.3M
    Typical spread (median absolute deviation)
    206K
    How far from its usual level
    +15.0
    Same report last year
    2.5M
    History used
    624 days
    2023-05-31: 2.5M2023-06-15: 2.9M2023-06-30: 2.2M2023-07-14: 2.1M2023-07-31: 2.3M2023-08-15: 2.4M2023-08-31: 1.9M2023-09-15: 2.1M2023-09-29: 2.1M2023-10-13: 2.3M2023-10-31: 2.4M2023-11-15: 2.3M2023-11-30: 2.3M2023-12-15: 1.9M2023-12-29: 2.4M2024-01-12: 2.7M2024-01-31: 2.0M2024-02-15: 2.8M2024-02-29: 1.9M2024-03-15: 1.6M2024-03-28: 2.3M2024-04-15: 4.2M2024-04-30: 5.9M2024-05-15: 6.2M2024-05-31: 6.9M
    the 31 May 2024 report24 earlier reportsnormal: 2.3M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

Showing the newest 40 of 91 entries; narrow the window or the kind of data to see older ones.

Not listed: 136 routine records (quarterly and annual reports, results releases, other 8-K items, material agreements and individual insider sales), counted over all history.

Identifiers and sources

How records are matched to this company, and what each source holds for it

Cik
0001832038
Ticker
IVVD
Domain
invivyd.com
Hq location
CT|NEW HAVEN| (1 unverified)
Lobbying client
adagio therapeutics, invivyd, invivyd formerly known as adagio therapeutics
Name
Adagio Therapeutics, Inc., Invivyd, Inc., Invivyd Netherlands B.V, Invivyd Security Corporation
Uei
EXVXXCKQ1ZL8
  • Federal lobbying disclosures (LDA)13 records, 53 data points15 Apr 2021 to 30 Sep 2026
  • SEC Form 13F institutional holdings1 record, 189 data points30 Sep 2021 to 30 Sep 2026
  • SEC EDGAR filings (8-K items, S-1, Form D, 10-K/10-Q)145 records12 Nov 2020 to 16 Nov 2026
  • SEC XBRL company facts (revenue, capex, R&D, backlog...)336 data points2 Jun 2020 to 29 Oct 2026
  • SEC Form 4 insider transactions29 records, 56 data points12 Aug 2021 to 18 Aug 2026
  • FINRA short interest (twice monthly)300 data points15 Sep 2022 to 30 Oct 2026
  • FINRA daily short sale volume (off-exchange)2106 data points13 Sep 2022 to 20 Nov 2026